Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • HBV
    (3)
  • Endogenous Metabolite
    (2)
  • Potassium Channel
    (1)
  • Others
    (3)
Filter
Search Result
Results for "

sodium taurocholate

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Isotope Products
    1
    TargetMol | Isotope_Products
  • Antibody Products
    3
    TargetMol | Antibody_Products
  • Disease Modeling
    2
    TargetMol | Disease_Modeling_Products
  • Reference Standards
    1
    TargetMol | Standard_Products
Sodium taurocholate
Taurocholate Sodium
TWA2417145-42-6
Sodium taurocholate is a biologically active compound that can inhibit bile duct injury induced by hepatic artery ligation by upregulating VEGF-A expression. It also exhibits immunomodulatory effects and can be used to induce pancreatitis models.
  • $50
In Stock
Size
QTY
Sodium taurocholate (Standard)
TMSM-2592145-42-6
Sodium taurocholate (Standard) is a reference standard for research and analysis in studies involving Sodium taurocholate. Sodium taurocholate is a biologically active compound that can inhibit bile duct injury induced by hepatic artery ligation by upregulating VEGF-A expression. It also exhibits immunomodulatory effects and can be used to induce pancreatitis models.
  • $61
7-10 days
Size
QTY
Taurocholic acid sodium salt hydrate
Taurocholic Acid sodium hydrate, Sodium taurocholate hydrate
T1138345909-26-4
Taurocholic acid sodium salt hydrate is a bile acid sodium salt hydrate that participates in fat emulsification and can be used to establish pancreatitis models.
  • $29
In Stock
Size
QTY
TargetMol | Citations Cited
BA-AZT1
T204321
BA-AZT1 acts as an inhibitor of HBV polymerase (HBV polymerase) and sodium taurocholate cotransporting polypeptide (NTCP). It hinders the secretion of viral capsid proteins HBsAg and HBeAg, with IC50 values of 0.65 µM and 13.42 µM, respectively, and inhibits HBV DNA replication with an IC50 of 0.70 µM.
  • Inquiry Price
Inquiry
Size
QTY
Rapavir
JH-B10
T206940
Rapavir (JH-B10) is a selective and potent inhibitor of sodium taurocholate co-transporting polypeptide (NTCP), with an IC50 value of 1.8 nM for taurocholic acid-d4 (TCA-d4) uptake. It exhibits antiviral activity against HBV infection by directly binding to NTCP and preventing the virus from entering cells. Rapavir is promising for HBV infection research.
  • Inquiry Price
Inquiry
Size
QTY
Bulevirtide
Myrcludex B, MyrB
T353732012558-47-1
Bulevirtide, also known by its developmental code name Myrcludex B, is a synthetic lipopeptide inhibitor of the sodium taurocholate cotransporting polypeptide (NTCP) that effectively inhibits the cellular entry of both hepatitis B virus (HBV) and hepatitis D virus (HDV) into hepatocytes, even in cases of compensated cirrhosis, showing significant potential for the treatment of chronic hepatitis D.
  • $499
Inquiry
Size
QTY
NPD8716
T71712956944-02-8
NPD8716 is a hepatitis B/D virus entry inhibitor, targeting sodium taurocholate cotransporting polypeptide (NTCP).
  • $1,520
6-8 weeks
Size
QTY
Taurocholic Acid-d4 Sodium
N-Choloyltaurine-d4 sodium
TMID-00522410279-93-3
Taurocholic Acid-d4 Sodium is a deuterium-labelled compound of Taurocholic Acid, which can be used for isotopic tracing.Taurocholic Acid is an immunomodulatory bile acid that plays an essential role in the digestion and absorption of fats and steroids in the intestine and liver.
  • $147
In Stock
Size
QTY